(five years after the FDA), Grant Bagley, MD, finally approved EECP for reimbursement, BUT only for these advanced conditions:

  • Canadian Class III or class IV angina (FDA approval is for Canadian Class I, II, III, IV angina)
  • A person’s condition is inoperable or at high risk of operative complications or post-operative failure.
  • A person’s coronary anatomy is not readily amenable to such procedures.
  • A person has co-morbid conditions which create excessive risk.
  • A prescription by a cardiologist or cardiothoracic surgeon.
  • The treatment program is limited to 35 hours maximum.